Oncology
High-Value Cancer Therapeutics
Sourcing pathways for immunotherapy, chemotherapy, and targeted oncology products.
Therapeutic Areas
Specialty sourcing across high-value therapeutic categories
For international distributors, CROs, and hospital vendors, McHade provides documented US sourcing for oncology, biologics, and rare disease therapies — with the handling controls and export documentation specialty programs require.
Focus areas
Three categories where specialty expertise matters
Each therapeutic focus has distinct sourcing, handling, and documentation requirements. Explore the area that matches your portfolio — then dive into the full focus page.
Oncology Product Portfolio
A specialized focus on high-value cancer therapeutics, including immunotherapy, chemotherapy, and targeted treatments.
Oncology programs often involve high-value products with strict handling requirements and complex cross-border documentation. McHade sources immunotherapy, chemotherapy, and targeted treatments through licensed US wholesaler channels — with batch records and export paperwork aligned to your destination market.
Explore focus areaSpecialty & Biologics
Procurement and logistics for complex large-molecule therapeutics requiring strict handling and sourcing controls.
Biologics and specialty drugs demand more than standard small-molecule sourcing. McHade procures large-molecule therapeutics with 2–8°C cold-chain aware handling where required, validated shipping systems for refrigerated transit, and chain-of-custody documentation your QA team can file.
Explore focus areaOrphan Drugs & Rare Disease
Sourcing solutions for hard-to-access orphan drugs and niche treatment pathways for rare disease populations.
Orphan drugs and rare disease therapies are often low-volume, limited-availability products that require specialized procurement — not catalog ordering. McHade helps partners source hard-to-access therapies for named-patient programs, institutional pathways, and niche treatment populations.
Explore focus areaSpecialty backbone
What supports every therapeutic program
The sourcing depth, handling controls, and documentation international partners expect for high-value and hard-to-access therapies.
Biologics
Large-Molecule Handling
2–8°C cold-chain aware procurement for biologics and specialty drugs.
Rare Disease
Orphan & Niche Access
Procurement support for low-volume, hard-to-source therapies.
Documentation
Export-Ready Programs
Batch records and cross-border paperwork for international partner programs.
Discuss your therapeutic sourcing requirements
Share your product categories, handling needs, destination markets, and program scope. Our team will review the requirements and respond with a compliant sourcing approach — turnaround depends on product complexity and market requirements.